In in vitro and in vivo studies of NAFLD, berberine has been shown to reduce pyroptosis by regulating the ROS/NLRP3 pathway (Mai et al., 2020). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.